Related references
Note: Only part of the references are listed.Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney
Sumito Ito et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics
Atsushi Yonezawa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Prediction of Fluoroquinolone-Induced Elevation in Serum Creatinine Levels: A Case of Drug-Endogenous Substance Interaction Involving the Inhibition of Renal Secretion
Y. Imamura et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Effects of a MATE Protein Inhibitor, Pyrimethamine, on the Renal Elimination of Metformin at Oral Microdose and at Therapeutic Dose in Healthy Subjects
H. Kusuhara et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity
Takanori Nakamura et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Potent and Specific Inhibition of mMate1-Mediated Efflux of Type I Organic Cations in the Liver and Kidney by Pyrimethamine
Sumito Ito et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
The Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by Cimetidine
Soichiro Matsushima et al.
DRUG METABOLISM AND DISPOSITION (2009)
Targeted Disruption of the Multidrug and Toxin Extrusion 1 (Mate1) Gene in Mice Reduces Renal Secretion of Metformin
Masahiro Tsuda et al.
MOLECULAR PHARMACOLOGY (2009)
Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A)
Tomohiro Terada et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Multidrug and toxic compound extrusion (MATE)-type proteins as anchor transporters for the excretion of metabolic waste products and xenobiotics
Y. Moriyama et al.
XENOBIOTICA (2008)
Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H+-organic cation antiporters
Yuko Tanihara et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2
Satohiro Masuda et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Drug-drug interactions involving membrane transporters in the human kidney
Meng Li et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants
T Fujita et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
A human transporter protein that mediates the final excretion step for toxic organic cations
M Otsuka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics
SH Wright
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions
M Hasegawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Share Paper
